Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia

Gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) represent a rare and heterogenous tumor entity. Importantly, the highly proliferative subgroup of neuroendocrine carcinoma (GEP-NEC) is characterized by high resistance to conventional chemotherapy. Consequently, there is an urgent need to id...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Dizdar, Levent, Oesterwind, Kira A., Riemer, Jasmin C., Werner, Thomas A., Mersch, Sabrina, Möhlendick, Birte, Schütte, Sina C., Verde, Pablo E., Raba, Katharina, Topp, Stefan A., Stoecklein, Nikolas H., Esposito, Irene, Knoefel, Wolfram T., Krieg, Andreas
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2016
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5352407/
https://ncbi.nlm.nih.gov/pubmed/28039474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14207
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares